Search Results - "Gorgulho, Joao"

Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade by Gorgulho, Joao, Roderburg, Christoph, Beier, Fabian, Bokemeyer, Carsten, Brümmendorf, Tim H., Luedde, Tom, Loosen, Sven H.

“…Background The search for biomarkers to identify ideal candidates for immune checkpoint inhibitor (ICI) therapy is fundamental. In this study, we analyze…”
Get full text

Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy by Gorgulho, Joao, Loosen, Sven H, Masood, Ramsha, Giehren, Franziska, Pagani, Francesca, Buescher, Gustav, Kocheise, Lorenz, Joerg, Vincent, Schmidt, Constantin, Schulze, Kornelius, Roderburg, Christoph, Kinkel, Eva, Fritzsche, Britta, Wehmeyer, Simon, Schmidt, Benjamin, Kachel, Paul, Rolling, Christina, Götze, Julian, Busch, Alina, Sinn, Marianne, Pereira-Veiga, Thais, Wikman, Harriet, Geffken, Maria, Peine, Sven, Matschl, Urte, Altfeld, Markus, Huber, Samuel, Lohse, Ansgar W, Beier, Fabian, Brümmendorf, Tim H, Bokemeyer, Carsten, Luedde, Tom, von Felden, Johann

“…Abstract Background The major breakthrough in cancer therapy with immune checkpoint inhibitors (ICIs) has highlighted the important role of immune checkpoints…”
Get full text

Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy by Rolles, Benjamin, Gorgulho, Joao, Tometten, Mareike, Roderburg, Christoph, Vieri, Margherita, Abels, Anne, Vucur, Mihael, Heymann, Felix, Tacke, Frank, Brümmendorf, Tim H, Luedde, Tom, Beier, Fabian, Loosen, Sven H

“…Immune checkpoint inhibitor (ICI) therapy represents a new standard of care for an increasing number of malignancies. Nevertheless, response rates and outcome…”
Get full text

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy by Loosen, Sven H, Gorgulho, Joao, Jördens, Markus S, Schulze-Hagen, Maximilian, Beier, Fabian, Vucur, Mihael, Schneider, Anne T, Koppe, Christiane, Mertens, Alexander, Kather, Jakob N, Tacke, Frank, Keitel, Verena, Brümmendorf, Tim H, Roderburg, Christoph, Luedde, Tom

“…Immune checkpoint inhibitors (ICIs) have led to a paradigm shift in cancer therapy, improving outcomes in the treatment of various malignancies. However, not…”
Get full text

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies by Wirtz, Theresa H., Loosen, Sven H., Schulze‐Hagen, Max, Gorgulho, Joao, Kandler, Jennis, Joerdens, Markus, Demir, Münevver, Mohr, Raphael, Bruners, Philipp, Kuhl, Christiane, Trautwein, Christian, Berres, Marie‐Luise, Tacke, Frank, Luedde, Tom, Roderburg, Christoph

“…Transarterial chemoembolization (TACE) is a therapeutic option for patients with intermediate‐stage hepatocellular carcinoma (HCC) or metastatic liver cancers…”
Get full text

Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer by Loosen, Sven H., Breuer, Annemarie, Tacke, Frank, Kather, Jakob N., Gorgulho, Joao, Alizai, Patrick H., Bednarsch, Jan, Roeth, Anjali A., Lurje, Georg, Schmitz, Sophia M., Brozat, Jonathan F., Paffenholz, Pia, Vucur, Mihael, Ritz, Thomas, Koch, Alexander, Trautwein, Christian, Ulmer, Tom F., Roderburg, Christoph, Longerich, Thomas, Neumann, Ulf P., Luedde, Tom

“…Surgical resection is the only potentially curative therapy for patients with biliary tract cancer (BTC), but 5-year survival rates after tumor resection have…”
Get full text

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis by Loosen, Sven H, Schulze‐Hagen, Max, Vucur, Mihael, Gorgulho, Joao, Paffenholz, Pia, Benz, Fabian, Mohr, Raphael, Demir, Münevver, Wree, Alexander, Kuhl, Christiane, Trautwein, Christian, Tacke, Frank, Bruners, Philipp, Luedde, Tom, Roderburg, Christoph

“…Background and Aim Transarterial chemoembolization (TACE) represents a standard of care for patients with intermediate‐stage hepatocellular carcinoma (HCC) or…”
Get full text

Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients by Gorgulho, Joao, Felden, Johann

“…LINKED CONTENT This article is linked to Hatanaka et al papers. To view these articles, visit https://doi.org/10.1111/apt.18237 and…”
Get full text

Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies by Gorgulho, Joao, Roderburg, Christoph, Beier, Fabian, Bokemeyer, Carsten, Brümmendorf, Tim H., Loosen, Sven H., Luedde, Tom

“…Background The search for biomarkers to identify suitable candidates for immune checkpoint inhibitor (ICI) therapy remains ongoing. We evaluate how soluble…”
Get full text

Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies by Gorgulho, Joao, Roderburg, Christoph, Heymann, Felix, Schulze‐Hagen, Maximilian, Beier, Fabian, Vucur, Mihael, Kather, Jakob N., Laleh, Narmin Ghaffari, Tacke, Frank, Brümmendorf, Tim H., Luedde, Tom, Loosen, Sven H.

“…Therapy with immune checkpoint inhibitors (ICIs) can lead to durable tumor control in patients with various advanced stage malignancies. However, this is not…”
Get full text

OS-027-YI Immune checkpoint profiles on circulating extracellular vesicles predict response to immunotherapy in heptaocellular carcinoma by Masood, Ramsha, Buescher, Gustav, Gorgulho, Joao, Giehren, Franziska, Pagani, Francesca, Kocheise, Lorenz, Jörg, Vincent, Schmidt, Constantin, Adlung, Lorenz, Waldmann, Moritz, Renne, Thomas, Krause, Jenny, Sauter, Guido, Ricklefs, Franz, Maire, Cecile, Shafiq, Mohsin, Lohse, Ansgar W., Huber, Samuel, Wege, Henning, Zimpel, Carolin, Marquardt, Jens U., Scheiner, Bernhard, Balcar, Lorenz, Pinter, Matthias, de Toni, Enrico, Piseddu, Ignazio, Khaled, Najib Ben, Schulze, Kornelius, von Felden, Johann

Get full text

OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy by Scheiner, Bernhard, Kang, Beodeul, Balcar, Lorenz, Radu, Pompilia, Reiter, Florian P, Adžić, Gordan, Guo, Jiang, Gao, Xu, Yuan, Xiao, Cheng, Long, Gorgulho, Joao, Schultheiß, Michael, Khaled, Najib Ben, Sinner, Friedrich, D'Alessio, Antonio, Pomej, Katharina, Saborowski, Anna, Schwacha-Eipper, Birgit, Zarka, Valentina, Lampichler, Katharina, Nishida, Naoshi, Lee, Pei-Chang, Krall, Anja, Saeed, Anwaar, Himmelsbach, Vera, Tesini, Giulia, Wietharn, Brooke, Huang, Yi-Hsiang, Vivaldi, Caterina, Masi, Gianluca, Vogel, Arndt, Schulze, Kornelius, Trauner, Michael, Stauber, Rudolf E., Kudo, Masatoshi, Dekervel, Jeroen, Parikh, Neehar, Dufour, Jean-François, Prejac, Juraj, Geier, Andreas, Bengsch, Bertram, von Felden, Johann, Venerito, Marino, Philipp, Alexander, Finkelmeier, Fabian, Ji, Fanpu, Wang, Hung-Wei, Rimassa, Lorenza, Pinato, David J., Bouattour, Mohamed, Chon, Hong Jae, Pinter, Matthias

Get full text

Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy by Loosen, Sven H, van den Bosch, Vincent, Gorgulho, Joao, Schulze-Hagen, Maximilian, Kandler, Jennis, Jördens, Markus S, Tacke, Frank, Loberg, Christina, Antoch, Gerald, Brümmendorf, Tim, Neumann, Ulf P, Kuhl, Christiane, Luedde, Tom, Roderburg, Christoph

“…Immune checkpoint inhibitors (ICIs) represent a new therapeutic standard for an increasing number of tumor entities. Nevertheless, individual response and…”
Get full text

A Arte Militar Bizantina: O Tratado de Velitatione Bellica (Séc. X) by Nisa, João Rafael Gorgulho

“…A tratadística militar bizantina é um assunto virgem em Portugal, mas tem despertado o interesse da comunidade científica internacional, sobretudo devido à sua…”
Get full text